Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Senti Biosciences, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20
   10-K10-KS-1
Revenues  4.32.80.6
            Revenue growth  55.2%387.8% 
Cost of goods sold  0.00.00.0
Gross profit  4.32.80.6
            Gross margin  100.0%100.0%100.0%
Selling, general and administrative   [+]40.821.39.3
Research and development  34.122.016.0
Other operating expenses   0.00.2
EBITDA   [+]-69.2-39.7-24.4
            EBITDA margin  -1615.3%-1437.8%-4305.3%
Depreciation and amortization  1.40.80.6
EBIT   [+]-70.6-40.5-24.9
            EBIT margin  -1647.9%-1465.7%-4404.9%
Non-recurring items   [+] 0.0-0.2
Interest income  1.70.00.1
Other income (expense), net   [+]10.7-14.94.7
Pre-tax income  -58.2-55.3-19.9
Income taxes  0.00.00.0
            Tax rate  0.0%0.0%0.0%
Net income  -58.2-55.3-19.9
            Net margin  -1358.1%-2003.6%-3509.2%
   
Basic EPS   [+]($2.23)($19.00)($1.43)
Diluted EPS   [+]($2.23)($19.00)($1.43)
   
Shares outstanding (basic)   [+]26.12.913.9
Shares outstanding (diluted)   [+]26.12.913.9
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy